Herbistry420
hybrid

Shiraz |

Caryophyllene-dominant
THC
11.7–15.8%
Dominant Terpene
Caryophyllene

About

Shiraz | is a hybrid cannabis strain. Lab samples test between 11.7% and 15.8% THC, with caryophyllene (0.76%) as the dominant terpene.

Why does Shiraz | feel pain-relieving?

Shiraz |'s pain-relieving effects are linked to its dominant caryophyllene (0.76%), one of the few terpenes that binds directly to CB2 cannabinoid receptors. Complemented by humulene (0.40%), associated with appetite suppression and anti-inflammatory effects.

Strain Profile

Energy
CalmingEnergizing
Potency
Low THCHigh THC

May Help With

Inflammation100%

Caryophyllene has strong anti-inflammatory properties

Pain68%

Caryophyllene binds to CB2 receptors for pain relief

Stress67%

Linalool has calming, stress-relieving properties

Anxiety58%

Linalool is known for anti-anxiety effects

Based on terpene research and reported effects. Not medical advice. Consult a healthcare professional for medical decisions.

Quick Info

Type
hybrid
Breeder
Not verified
THC
11.7–15.8%
Chemotype
Caryophyllene-dominant

What is Caryophyllene?

Spicy, peppery terpene found in black pepper, cloves, and cinnamon.

Learn more →

Share

Share
← Back to all strains

About Shiraz |

Is Shiraz | indica or sativa?
Shiraz | is a hybrid cannabis strain. Hybrids combine characteristics of both indica and sativa genetics.
What is the THC content of Shiraz |?
Shiraz | typically tests at 11.7% to 15.8% THC.
What terpenes are in Shiraz |?
The dominant terpenes in Shiraz | are Caryophyllene, Humulene, Limonene. Terpenes influence the aroma, flavor, and effects of a cannabis strain.